Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
International Journal of Molecular Sciences|August 27, 2021
Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma CellsAlessia Salzillo, Angela Ragone, Annamaria Spina, et al.Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?Luigi Sapio, Angela Ragone, Annamaria Spina, et al.Frontiers in Pharmacology|March 11, 2022
Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell LinesAngela Ragone, Alessia Salzillo, Annamaria Spina, et al.European Journal of Cell Biology|February 3, 2023
Forskolin affects proliferation, migration and Paclitaxel-mediated cytotoxicity in non-small-cell lung cancer cell lines via adenylyl cyclase/cAMP axisAlessia Salzillo, Angela Ragone, Annamaria Spina, et al.International Journal of Molecular Sciences|June 2, 2021
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer TreatmentsErsilia Nigro, Aurora Daniele, Alessia Salzillo, et al.Cells|April 25, 2025
Combining AdipoRon with Paclitaxel Unveils Synergistic Potential in Non-Small Cell Lung Cancer Cells via AMPK-ERK1/2 SignalingSanober Kafeel, Giuseppina Palmiero, Alessia Salzillo, et al.Cancers|October 31, 2020
Targeting CREB in Cancer Therapy: A Key Candidate or One of Many? An UpdateLuigi Sapio, Alessia Salzillo, Angela Ragone, et al.Cancers|August 10, 2024
Adiponectin Receptor Agonist AdipoRon Inhibits Proliferation and Drives Glycolytic Dependence in Non-Small-Cell Lung Cancer CellsSanober Kafeel, Angela Ragone, Alessia Salzillo, et al.Biomolecules|June 26, 2025
Unravelling the Adiponectin Hallmark and Exploring the Therapeutic Potential of Its Receptor Agonists in Cancer Metabolic ReprogrammingSanober Kafeel, Giuseppina Palmiero, Alessia Salzillo, et al.Cancers|October 14, 2023
Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with ImmunotherapyDanilo Rocco, Luigi Della Gravara, Angela Ragone, et al.Pageof 2